Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
基本信息
- 批准号:10330561
- 负责人:
- 金额:$ 18.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-10 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adrenal Cortex HormonesAirAsthmaBiological ModelsBiological ProductsCell Culture TechniquesCell LineCell modelCellsChildChildhoodChildhood AsthmaClinicalCodeEmergency department visitEnvironmentEpithelialEpithelial CellsFibroblastsFrequenciesGene ExpressionGenesGenetic PolymorphismGoalsHeterogeneityHospitalizationHumanIncidenceInfectionInflammationInhalationInnate Immune ResponseInterferonsLearningLiquid substanceLungLung diseasesModelingMorbidity - disease rateMyofibroblastNatural HistoryNosePathogenesisPatientsPhenotypePlayPrimary InfectionRegulationReportingResearchResearch PersonnelResearch TechnicsResourcesRespiratory Syncytial Virus InfectionsRhinovirusRhinovirus infectionRiskRoleSchoolsSeriesSignal Transduction PathwayStromal CellsSubgroupTechniquesTestingTimeTrainingTranslational ResearchViralVirusVirus DiseasesVirus Replicationairway epitheliumairway remodelingasthma exacerbationasthmaticasthmatic airwayasthmatic patientbasecareercohortcostcytokineexperimental studyfunctional declineloss of functionpatient orientedpatient oriented researchpreventprogramsprospectivepulmonary functionpulmonary function declineresponsesensortranslational study
项目摘要
Project Summary
Asthma exacerbations among U.S children result in 640,000 emergency department visits and 14 million
missed school days annually. Viral infections trigger the majority of exacerbations in children, of which human
rhinoviruses (HRV) are the most common. The airway epithelium plays central roles in regulating
inflammation, airway remodeling responses, and innate immune responses to infection. The most striking
response of airway epithelial cells (AECs) to viral infection is expression of type I and III interferons (IFN I/III)
and IFN stimulated genes (ISG). Some have reported deficient IFN I/III responses to viral infection by
asthmatic AECs and postulated that deficient epithelial IFN responses to viruses predispose to exacerbations,
whereas others have not observed differences in AEC IFN responses to viruses between asthmatic and
healthy AECs. In our unique cohort of well characterized asthmatic and healthy children, from whom we obtain
bronchial and nasal AECs and conduct mechanistic experiments using air-liquid-interface organotypic culture
models, we have observed significant heterogeneity in IFN I/III responses to HRV and RSV infection. For
example, among our asthmatic AEC donors we have noted associations between high type I/III IFN responses
and lower donor lung function, as well as distinct subgroups of exacerbation prone asthmatics with deficient
IFN I/III responses to HRV. Heterogeneity in AEC IFN I/III responses to viral infections may be explained by
polymorphisms in genes coding for viral sensors and/or key steps in signal transduction pathways upstream of
IFN I and III. The overall goal my research program is to understand how airway epithelial responses
influence viral-triggered exacerbations and airway remodeling mechanisms in asthmatic children. In the
first aim, using primary cells from children with asthma we will test our hypothesis that polymorphisms in
genes coding for viral sensors, and/or key steps in signal transduction pathways upstream of IFN responses,
contribute to heterogeneity in IFN I/III responses to HRV infection by AECs from asthmatic children. In the
second aim, we will prospectively follow a cohort of asthmatic children to test our hypothesis that deficient
AEC IFN I/III responses to HRV are associated with a greater incidence of viral-triggered exacerbations in AEC
donors. In the final aim, we will test our hypothesis that excessively high IFN I/III responses by asthmatic
AECs to HRV are associated with lung function decline among AEC donors, and we will interrogate potential
mechanisms whereby excessively high IFN I/III responses may promote proliferation and activation of lung
stromal cells. The studies conducted in my research program and unique resource of primary airway epithelial
cells from clinically well characterized asthmatic children provide an exceptional training environment for young
investigators dedicated to a career in mechanistic patient-oriented research to learn translational research
techniques to investigate the role of the airway epithelium in pediatric lung diseases and viral infection.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON S DEBLEY其他文献
JASON S DEBLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON S DEBLEY', 18)}}的其他基金
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
- 批准号:
10558633 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
- 批准号:
10446799 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
- 批准号:
10265757 - 财政年份:2020
- 资助金额:
$ 18.45万 - 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
- 批准号:
10552683 - 财政年份:2020
- 资助金额:
$ 18.45万 - 项目类别:
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
气道上皮信号失调是哮喘儿童气道重塑的驱动因素
- 批准号:
9130413 - 财政年份:2015
- 资助金额:
$ 18.45万 - 项目类别:
NONINVASIVE MEASURES OF AIRWAY INFLAMMAITON AND AIRFLOW OBSTRUCTION IN WHEEZY
喘息时气道炎症和气流阻塞的非侵入性治疗
- 批准号:
7603558 - 财政年份:2007
- 资助金额:
$ 18.45万 - 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY DURING AND FOLLOWING OF ASTHMA
哮喘期间和之后的气流阻塞和气道生物标志物
- 批准号:
7603551 - 财政年份:2007
- 资助金额:
$ 18.45万 - 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY INFLAMATION
气流阻塞和气道炎症的生物标志物
- 批准号:
7379438 - 财政年份:2006
- 资助金额:
$ 18.45万 - 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
- 批准号:
6956540 - 财政年份:2005
- 资助金额:
$ 18.45万 - 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
- 批准号:
7103668 - 财政年份:2005
- 资助金额:
$ 18.45万 - 项目类别:
相似国自然基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
- 批准号:51976048
- 批准年份:2019
- 资助金额:61.0 万元
- 项目类别:面上项目
相似海外基金
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
Operating Grants
Urban planning, siting of air pollution sources, and asthma disparities
城市规划、空气污染源选址和哮喘差异
- 批准号:
10567693 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
Evaluation of radon progeny and air pollution effects in asthma
评估氡子体和空气污染对哮喘的影响
- 批准号:
10723709 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
Action towards health equity and improved air quality in the Duwamish Valley: A multilevel asthma intervention
杜瓦米什山谷的健康公平和空气质量改善行动:多层次哮喘干预
- 批准号:
10562132 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
Investigating the interactions of air pollution and an anti-inflammatory asthma medication using scRNA sequencing
使用 scRNA 测序研究空气污染和抗炎哮喘药物的相互作用
- 批准号:
485433 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
Salary Programs
Molecular Mechanisms for Resolving Air Pollution Induced Pulmonary Inflammation: Potential Differences by Asthma and Sex (RAPIDAS)
解决空气污染引起的肺部炎症的分子机制:哮喘和性别的潜在差异(RAPIDAS)
- 批准号:
10718525 - 财政年份:2023
- 资助金额:
$ 18.45万 - 项目类别:
There's something in the air: disentangling the role of airborne microbes and pollutants in the inflammatory response of asthma along a latitudinal gradient in Canada
空气中弥漫着某种东西:沿着加拿大的纬度梯度,理清空气中的微生物和污染物在哮喘炎症反应中的作用
- 批准号:
571457-2021 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:
Alliance Grants
Puerto Rico Asthma Integrated Response Program (PR-AIR)
波多黎各哮喘综合应对计划 (PR-AIR)
- 批准号:
10705253 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:
Puerto Rico Asthma Integrated Response Program (PR-AIR)
波多黎各哮喘综合应对计划 (PR-AIR)
- 批准号:
10534086 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:
Contextualizing Asthma Self-Management with Measures of Indoor Air Quality for Black Adults with Uncontrolled Asthma
将哮喘自我管理与哮喘不受控制的黑人成人的室内空气质量测量结合起来
- 批准号:
10671775 - 财政年份:2022
- 资助金额:
$ 18.45万 - 项目类别:














{{item.name}}会员




